TY - JOUR
T1 - Globally altered epigenetic landscape and delayed osteogenic differentiation in H3.3-G34W-mutant giant cell tumor of bone
AU - Lutsik, Pavlo
AU - Baude, Annika
AU - Mancarella, Daniela
AU - Öz, Simin
AU - Kühn, Alexander
AU - Toth, Reka
AU - Hey, Joschka
AU - Toprak, Umut H.
AU - Lim, Jinyeong
AU - Nguyen, Viet Ha
AU - Jiang, Chao
AU - Mayakonda, Anand
AU - Hartmann, Mark
AU - Rosemann, Felix
AU - Breuer, Kersten
AU - Vonficht, Dominik
AU - Grünschläger, Florian
AU - Lee, Suman
AU - Schuhmacher, Maren Kirstin
AU - Kusevic, Denis
AU - Jauch, Anna
AU - Weichenhan, Dieter
AU - Zustin, Jozef
AU - Schlesner, Matthias
AU - Haas, Simon
AU - Park, Joo Hyun
AU - Park, Yoon Jung
AU - Oppermann, Udo
AU - Jeltsch, Albert
AU - Haller, Florian
AU - Fellenberg, Jörg
AU - Lindroth, Anders M.
AU - Plass, Christoph
N1 - Publisher Copyright:
© 2020, The Author(s).
PY - 2020/12/1
Y1 - 2020/12/1
N2 - The neoplastic stromal cells of giant cell tumor of bone (GCTB) carry a mutation in H3F3A, leading to a mutant histone variant, H3.3-G34W, as a sole recurrent genetic alteration. We show that in patient-derived stromal cells H3.3-G34W is incorporated into the chromatin and associates with massive epigenetic alterations on the DNA methylation, chromatin accessibility and histone modification level, that can be partially recapitulated in an orthogonal cell line system by the introduction of H3.3-G34W. These epigenetic alterations affect mainly heterochromatic and bivalent regions and provide possible explanations for the genomic instability, as well as the osteolytic phenotype of GCTB. The mutation occurs in differentiating mesenchymal stem cells and associates with an impaired osteogenic differentiation. We propose that the observed epigenetic alterations reflect distinct differentiation stages of H3.3 WT and H3.3 MUT stromal cells and add to H3.3-G34W-associated changes.
AB - The neoplastic stromal cells of giant cell tumor of bone (GCTB) carry a mutation in H3F3A, leading to a mutant histone variant, H3.3-G34W, as a sole recurrent genetic alteration. We show that in patient-derived stromal cells H3.3-G34W is incorporated into the chromatin and associates with massive epigenetic alterations on the DNA methylation, chromatin accessibility and histone modification level, that can be partially recapitulated in an orthogonal cell line system by the introduction of H3.3-G34W. These epigenetic alterations affect mainly heterochromatic and bivalent regions and provide possible explanations for the genomic instability, as well as the osteolytic phenotype of GCTB. The mutation occurs in differentiating mesenchymal stem cells and associates with an impaired osteogenic differentiation. We propose that the observed epigenetic alterations reflect distinct differentiation stages of H3.3 WT and H3.3 MUT stromal cells and add to H3.3-G34W-associated changes.
UR - http://www.scopus.com/inward/record.url?scp=85094116778&partnerID=8YFLogxK
U2 - 10.1038/s41467-020-18955-y
DO - 10.1038/s41467-020-18955-y
M3 - Article
C2 - 33110075
AN - SCOPUS:85094116778
SN - 2041-1723
VL - 11
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 5414
ER -